MORE than two million Australians living with osteoporosis1 are set to benefit from the first once-a-month osteoporosis therapy, after it was today listed on the Pharmaceutical Benefits Scheme (PBS).
01/07/2009
RESEARCHERS at the National Space Biomedical Research Institute (NSBRI) developing an ultrasound device which will assist the fight against bone disorders.
19/02/2009
Roche has announced that its Phase III clinical trial evaluation of ocrelizumab as a treatment for seropositive rheumatoid arthritis (RA) patients with a previous inadequate response to methotrexate (MTX), has met its primary efficacy endpoint.
14/12/2009
An Australian regenerative medicine company, Mesoblast, has been granted a key patent by the United States Patent and Trademark Office (USPTO), providing them with exclusive commercial protection for its bone tissue generating products through to at least 2019 in the US.
05/03/2010
SCHERING-PLOUGH today announced that the US Food and Drug Administration (FDA) has approved new labelling for its PEGINTRON (peginterferon alfa-2b) and REBETOL (ribavirin, USP) combination therapy for treating chronic hepatitis C in patients three years of age and older with compensated liver disease.
16/03/2009
Medtronic has been selected as one of Massachusetts Institute of Technology (MIT) Technology Review's 50 most innovative companies. The company was recognised for its development and introduction of Deep Brain Stimulation (DBS) Therapy, which helps treat neurological conditions by delivering controlled electrical pulses to a specific part of the brain.
05/03/2010
The Food and Drug Administration (FDA) has issued safety information regarding Negative Pressure Wound Therapy (NPWT) systems. Healthcare professionals have been notified by the US authority regarding deaths and serious complications associated with the use of these systems.
24/11/2009
THE FIRST artemisinin-based combination therapy (ACT) developed medication for children suffering from malaria has been designed by Novartis and the Medicines for Malaria Venture.
28/01/2009
THE NATURAL Orifice Surgery Consortium for Assessment and Research (NOSCAR) has announced Olympus' continuing commitment to funding research in an emerging minimally invasive transdisciplinary therapy known as Natural Orifice Translumenal Endoscopic Surgery.
24/07/2009
SAGENT Pharmaceuticals has announced FDA approval of its Azithromycin for Injection therapy developed for treatment of bacterial infections.
31/03/2009
NOVARTIS has received a positive opinion supporting European Union (EU) approval of Glivec (imatinib) as a post-surgery treatment for patients at significant risk of relapse following removal of gastrointestinal stromal tumours (GIST).
24/03/2009
Data from the 'AIDS Epidemic Update' shows that at 33.4 million, there are more people living with HIV than ever before. People are living longer due to the beneficial effects of antiretroviral therapy and population growth.
25/11/2009
Researchers at the University of Sydney are using virtual reality techniques to study how thinking tasks impact the 'freezing' of feet often experienced by people with Parkinson's Disease (PD). They how their findings will offer new directions for treating the disease.
11/03/2010
High-risk melanoma patients treated with radiation after surgery have a significantly lower risk of their cancer returning to the lymph nodes (19%) compared to those patients who don’t have radiation therapy (31%).
06/11/2009
MERCK Sharp and Dohme has announced its type 2 diabetes therapy, Janumet, has been approved by the Therapeutic Goods Administration (TGA).
27/04/2009
PRIMA Biomed has secured $12m in funding to advance the commercialisation of the CVac ovarian cancer vaccine treatment product.
17/03/2009
University of Wollongong (UOW) researchers have developed a prostate cancer treatment device to enhance a US company’s Prostate Immobilizer Balloon System.
09/11/2009
Sydney University investigators are set to undertake a systematic and comprehensive analysis of speech and language recovery experienced by traumatic brain injury (TBI) sufferers using a new web-based technology called AphasiaBank.
17/12/2009
KIDNEY Health Australia has announced it has set up a national multi-disciplinary working party which has been designed to look at attitudes to dialysis and resources available for dialysis in Australian renal units which are under stress to cope with growing numbers.
16/06/2009
THE NSW Government has announced the approval of a $99 million redevelopment of the Children’s Medical Research Institute at Westmead Hospital.
06/10/2009